Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013
- PMID: 30649461
- PMCID: PMC6380406
- DOI: 10.1093/neuonc/noy195
Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013
Abstract
Background: We present a national surveillance report on malignant primary brain and other central nervous system (CNS) tumors diagnosed in the Canadian population in 2009-2013.
Methods: Patients were identified through the Canadian Cancer Registry, an administrative dataset that includes cancer incidence data from all provinces/territories in Canada. Tumor types were classified by site and histology using the definitions from the Central Brain Tumor Registry of the United States (CBTRUS). Incidence rates (IRs) and 95% confidence intervals (CIs) were calculated per 100000 person-years (py) and age-standardized to the 2011 Canadian population for comparisons within Canada and to the 2000 United States population for comparisons with the US.
Results: Overall, 12515 malignant brain and other CNS tumors were diagnosed in the Canadian population in 2009-2013 (IR: 8.71/100000 py; 95% CI: 8.56, 8.86); 7085 were among males (IR: 10.06/100000 py; 95% CI: 9.82, 10.29) and 5430 among females (IR: 7.41/100000 py; 95% CI: 7.22, 7.61). Of these, 12115 were classifiable according to histological subgroups defined by CBTRUS. The most common histology was glioblastoma (IR: 4.06/100000 py; 95% CI: 3.95, 4.16). Among those aged 0-19 years, 1130 malignant brain and CNS tumors were diagnosed in 2009-2013 (IR: 3.36/100000 py; 95% CI: 3.16, 3.56). The most common histology among the pediatric population was embryonal tumor (IR: 0.74/100000 py; 95% CI: 0.65, 0.84).
Conclusions: These data represent an initial detailed report on the frequency and distribution of primary malignant brain and other CNS tumors diagnosed in the Canadian population in 2009-2013. The reported distributions of tumor diagnoses by sex and age reflected expected patterns based on the literature from similar populations. A report incorporating data on nonmalignant primary brain tumors is forthcoming.
Keywords: Canadian surveillance report; epidemiology; malignant brain neoplasms; malignant central nervous system neoplasms; neuro-oncology.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology.
Figures
Comment in
-
Brain and central nervous system tumor statistics: access to accurate data for all countries is critical!Neuro Oncol. 2019 Feb 19;21(3):291-292. doi: 10.1093/neuonc/noy205. Neuro Oncol. 2019. PMID: 30649531 Free PMC article. No abstract available.
References
-
- Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2017 2017. cancer.ca/Canadian-CancerStatistics-2017-EN.pdf. Accessed May 19, 2018.
-
- Davis F, Nagamuthu C, Ross J, Megyesi J. Current status of brain tumor surveillance in Canada and why it matters. J Registry Manag. 2015;42(4):139–145. - PubMed
-
- Government of Canada SC. Canadian Cancer Registry (CCR) http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurveyandSDDS=3207#a3. Published January 19, 2018. Accessed July 30, 2018.
-
- Steliarova-Foucher E, Stiller C, Lacour B, et al. . International Classification of Childhood Cancer, third edition. Cancer. 2005;103(7):1457–1467. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
